Using Both TAS-102 and Regorafenib in Metastatic CRC Patients

Using Both TAS-102 and Regorafenib in Metastatic CRC Patients

obr

3 years
915 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Alan P. Venook, MD, FAnnual Meeting of Helen Diller Family Comprehensive Cancer Center gives his perspective on how to use both TAS-102 and regorafenib in patients with metastatic colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Up Next Autoplay